DENTSPLY SIRONA Inc. XRAY
8.60 USD -0.35 (-3.86%)
Regular-session close
8.58 -0.02 -0.23%
After hours · Nov 17, 4:21 PM ET
8.59 Day range 9.00
8.14 52-week range 14.76
- YTD
- -24.76%
- 1 year
- -17.23%
News
fool.com Dentsply Sirona: 3 Key Takeaways for Long-Term Investors Management reduced full-year 2026 sales guidance to approximately $3.5 billion. Wellspect Healthcare revenue grew 10% year over year to $92 million.benzinga.com UBS Maintains Buy on Dentsply Sirona, Lowers Price Target to $13 UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $17 to $13.
zacks.com New Strong Sell Stocks for November 13th XRAY, BROS and GECC have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2026.
seekingalpha.com DENTSPLY SIRONA Inc. (XRAY) Q3 2026 Earnings Call Transcript DENTSPLY SIRONA Inc. ( XRAY ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Suzanne Hatcher Daniel Scavilla - President, CEO, Interim Principal Financial Officer & Director…
marketbeat.com DENTSPLY SIRONA Q3 Earnings Call Highlights DENTSPLY SIRONA NASDAQ: XRAY lowered its full-year earnings outlook after third-quarter sales fell across its dental businesses, as pressure from European distributor inventory reductions, the Middle…
zacks.com XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook Cut DENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.
benzinga.com DraftKings Posts Downbeat Q3 Results, Joins Atlassian, Natera And Other Big Stocks Moving Lower In Friday’s Pre-Market Session Stock futures mixed as DraftKings plunged 21% after earnings missed estimates and FY26 guidance was cut; several other stocks also fell premarket.
zacks.com Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
zacks.com Dentsply International (XRAY) Q3 Earnings and Revenues Miss Estimates Dentsply International (XRAY) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.37 per share a year ago.
benzinga.com Dentsply Sirona Q3 2026 Earnings Call Transcript Dentsply Sirona (NASDAQ:XRAY) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.benzinga.com Dentsply Sirona Lowers FY2026 Adj EPS Guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 Est; Narrows FY2026 Sales Guidance from $3.500B-$3.600B to $3.500B vs $3.570B Est Dentsply Sirona (NASDAQ:XRAY) lowers FY2026 Adj EPS guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 analyst estimate. Narrows FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500…
benzinga.com Dentsply Sirona Q3 Adj. EPS $0.29 Misses $0.31 Estimate, Sales $836.000M Miss $862.001M Estimate Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.31 by 6.45 percent. This is a 21.62 percent decrease over earnings of…
globenewswire.com Dentsply Sirona Reports Third Quarter 2026 Results News Summary Q3 2026 net sales of $836 million Q3 2026 GAAP gross margin of 52.9% , GAAP diluted loss per share of ($0.01) Q3 2026 adjusted gross margin of 54.5% , adjusted EBITDA margin of 17.3% ,…
zacks.com DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? DENTSPLY SIRONA faces Q3 earnings pressure from weak dental demand, tariff costs and segment challenges, while Wellspect's growth may offer some relief.
prnewswire.com Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
benzinga.com ServiceNow To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday Analysts raised targets for RS, CVLT, SLB, RNG and VEEV; cut targets for XRAY and FUN while maintaining ratings.benzinga.com Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $13 Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.
benzinga.com Mizuho Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12 Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.
globenewswire.com Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5 CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and…
zacks.com Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.
defenseworld.net Dentsply Sirona (NASDAQ: XRAY) secures covenant relief in debt amendments What happened Dentsply Sirona Inc. (NASDAQ: XRAY) said on October 8, 2026, that lenders consented to amendments to its revolving credit facility and related note agreements. The company entered the…
globenewswire.com Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity™ portfolio, including the Surity™ Urinary Management System and Surity™ Female and Male…
globenewswire.com Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and…
defenseworld.net DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Time to Sell? Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) hit a new 52-week low on Friday. The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares. The…
defenseworld.net Engineers Gate Manager LP Boosts Stake in DENTSPLY SIRONA Inc. $XRAY Engineers Gate Manager LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 451.5% in the undefined quarter, according to the company in its most recent 13F filing with the…
zacks.com Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
zacks.com XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
prnewswire.com Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
